ClinicalTrials.govpublic full text
Phenotypical Approach of the Drug Metabolizing Hormones Activity Before and After Roux-en Y-Gastric Bypass
obesity, drug metabolizing enzymes and drug transporter, roux-en y-gastric bypass, drug availability, bmi over 35kg/m² and comorbidities or >40kg/m², interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830458
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.